Document is current
Any future updates will be listed below
-
Authors
Khosravi, Bahram
LaClair, Kathrine D
Riemenschneider, Henrick
Zhou, Qihui https://orcid.org/0000-0001-5733-9820
Frottin, Frédéric
Mareljic, Nikola
Czuppa, Mareike
Farny, Daniel
Hartmann, Hannelore
Michaelsen, Meike
Arzberger, Thomas
Hartl, F Ulrich https://orcid.org/0000-0002-7941-135X
Hipp, Mark S https://orcid.org/0000-0002-0497-3016
Edbauer, Dieter https://orcid.org/0000-0002-7186-4653
-
Funding
Funding for this research was provided by:
NOMIS Stiftung
EC | Seventh Framework Programme (617198)
Deutsche Forschungsgemeinschaft (EXC 2145)
Hans und Ilse Breuer Foundation
- License Information
-
More Information
Article History
Received: 28 June 2019
Revised: 12 February 2020
Accepted: 14 February 2020
First Online: 16 March 2020
Conflict of interest
: D.E. holds a patent on “Dipeptide‐repeat proteins as therapeutic target in neurodegenerative diseases with hexanucleotide repeat expansion” (EP2948777 and US10066007).
